Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Virtual Reality for Cognitive Enhancement in Schizophrenia: A Randomized Controlled Trial

NCT07111689 is registered in ClinicalTrials.gov with Saglik Bilimleri Universitesi as lead sponsor.

NCT NCT07111689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07111689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Virtual Reality for Cognitive Enhancement in Schizophrenia: A Randomized Controlled Trial
Lead sponsor
Saglik Bilimleri Universitesi
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2023
Completion date
June 13, 2024
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive ability general, schizophrenia disorder, virtual reality, virtual reality cognitive training